Valero Energy Partners LP Reports 2017 First Quarter Results
Apr 28, 2017 11:11 am UTC| Business
Reported net income attributable to partners of $58 million and EBITDA attributable to the Partnership of $79 million.Reported net cash provided by operating activities of $75 million and distributable cash flow of $74...
BeyondSpring Provides Quarterly Operational Update and Full Year 2016 Results
Apr 28, 2017 11:00 am UTC| Business
NEW YORK, April 28, 2017 -- BeyondSpring Inc. (NASDAQ Capital Markets:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology cancer therapies, today provided an...
OncoCyte Continues to Make Progress Towards Commercialization; Reports First Quarter 2017 Results
Apr 28, 2017 11:00 am UTC| Business
Expects to Report Results of 300 Patient RD Validation Study on May 22, 2017 Conference Call Scheduled for May 22, 2017 at 4:30pm ET ALAMEDA, Calif., April 28, 2017 -- OncoCyte Corporation (NYSE MKT:OCX), a developer...
IRADIMED CORPORATION Announces First Quarter 2017 Financial Result
Apr 28, 2017 11:00 am UTC| Business
Reports first quarter 2017 revenue of $5.2 millionReports first quarter 2017 GAAP diluted EPS of $(0.02) and non-GAAP diluted EPS of $0.00Announces $8 million share repurchase program WINTER SPRINGS, Fla., April 28, 2017...
Altra Reports First-Quarter 2017 Results
Apr 28, 2017 11:00 am UTC| Business
BRAINTREE, Mass., April 28, 2017 -- Altra Industrial Motion Corp.(Nasdaq:AIMC), a global manufacturer and marketer of electromechanical power transmission and motion control products, today announced unaudited financial...
WisdomTree Announces First Quarter 2017 Results
Apr 28, 2017 11:00 am UTC| Business
$0.05 diluted EPS for the quarter Declares $0.08 quarterly dividend NEW YORK, April 28, 2017 -- WisdomTree Investments, Inc. (NASDAQ:WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”)...
Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 28, 2017 11:00 am UTC| Business
CHAPEL HILL, N.C., April 28, 2017 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious...
Arctic Ambitions and Tariff Tremors: Trump’s Greenland Gambit Rattles Global Markets